Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics granted 18,600 restricted stock units to three newly hired non-executive employees. The grants were made under the company’s 2025 Inducement Equity Plan and approved by the Compensation Committee as a material inducement for employment.
Key figures
- Rsus granted
- 18600
- Employees hired
- 3
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.